{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:27:03Z","timestamp":1793957223722,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","award":["18-0533"],"award-info":[{"award-number":["18-0533"]}],"id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107930","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:48:27Z","timestamp":1789688907000},"page":"107930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neurometabolic brain changes in MS associated with fatigue and anxiety"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-2166","authenticated-orcid":false,"given":"Ibrahim","family":"Khormi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oun","family":"Al-iedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Fazlollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Lea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-7866","authenticated-orcid":false,"given":"Saadallah","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2026.107930_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011625","article-title":"Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla","volume":"5","author":"Aboul-Enein","year":"2010","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12929-017-0323-2","article-title":"Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis","volume":"24","author":"Al-Iedani","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.msard.2026.107930_bib0021","doi-asserted-by":"crossref","DOI":"10.4172\/2254-609X.100095","article-title":"A longitudinal, observational study of the effect of dimethyl fumarate on hippocampal metabolites in RRMS using 1H-MR spectroscopy","volume":"7","author":"Al-Iedani","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.msard.2026.107930_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejrad.2018.09.020","article-title":"Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy","volume":"108","author":"Al-Iedani","year":"2018","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.msard.2026.107930_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mri.2020.09.001","article-title":"Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients(\u2606)","volume":"74","author":"Al-Iedani","year":"2020","journal-title":"Magn. Reson. ImAging"},{"issue":"6","key":"10.1016\/j.msard.2026.107930_bib0016","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/jon.13032","article-title":"Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy","volume":"32","author":"Al-iedani","year":"2022","journal-title":"J. Neuroimaging"},{"issue":"5","key":"10.1016\/j.msard.2026.107930_bib0007","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10548-018-0652-9","article-title":"Clinical correlations of brain lesion location in multiple sclerosis: voxel-based analysis of a large clinical trial dataset","volume":"31","author":"Altermatt","year":"2018","journal-title":"Brain Topogr."},{"issue":"5","key":"10.1016\/j.msard.2026.107930_bib0037","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It\u2019s not that simple","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann. thorac. surg."},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0008","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/01616412.2018.1547813","article-title":"Structural and cognitive correlates of fatigue in progressive multiple sclerosis","volume":"41","author":"Andreasen","year":"2019","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jon.12836","article-title":"Biochemical correlations with fatigue in multiple sclerosis detected by MR 2D localized correlated spectroscopy","volume":"31","author":"ARM","year":"2021","journal-title":"J. Neuroimag."},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0052","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.24202","article-title":"In vivo evidence of glutamate toxicity in multiple sclerosis","volume":"76","author":"Azevedo","year":"2014","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0066","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0924-977X(03)00100-7","article-title":"Glutamate and anxiety","volume":"14","author":"Bergink","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.msard.2026.107930_bib0068","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.pbb.2011.04.010","article-title":"New perspectives in glutamate and anxiety","volume":"100","author":"Bermudo-Soriano","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0003","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp.2009.201574","article-title":"T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis","volume":"82","author":"Bodini","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.msard.2026.107930_bib0056","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/antiox10091407","article-title":"In vivo brain GSH: MRS methods and clinical applications","volume":"10","author":"Bottino","year":"2021","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0030","first-page":"611","article-title":"Glutamatergic and neuronal dysfunction in gray and white matter: a spectroscopic imaging study in a large schizophrenia sample","volume":"43","author":"Bustillo","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.msard.2026.107930_bib0029","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jad.2018.12.064","article-title":"Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia","volume":"246","author":"Bustillo","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"14","key":"10.1016\/j.msard.2026.107930_bib0014","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/WNL.0b013e3181f5d4da","article-title":"Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis","volume":"75","author":"Calabrese","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107930_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-88-470-0391-0_1","article-title":"Neuropathological advances in multiple sclerosis","author":"Capello","year":"2007","journal-title":"Neurodegener. Mult. Scler."},{"issue":"Pt 11","key":"10.1016\/j.msard.2026.107930_bib0038","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/brain\/awh640","article-title":"1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review","volume":"128","author":"Caramanos","year":"2005","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.msard.2026.107930_bib0024","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/1352458514533400","article-title":"Glutathione in multiple sclerosis: more than just an antioxidant?","volume":"20","author":"Carvalho","year":"2014","journal-title":"Mult. Scler. J."},{"issue":"Pt 10","key":"10.1016\/j.msard.2026.107930_bib0002","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/brain\/awf240","article-title":"Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis","volume":"125","author":"Chard","year":"2002","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.msard.2026.107930_bib0049","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/brain\/awf240","article-title":"Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing\u2013remitting multiple sclerosis","volume":"125","author":"Chard","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1352458510384010","article-title":"Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T","volume":"17","author":"Choi","year":"2011","journal-title":"Mult. Scler. J."},{"issue":"8","key":"10.1016\/j.msard.2026.107930_bib0053","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/1352458517711568","article-title":"In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis","volume":"24","author":"Choi","year":"2018","journal-title":"Mult. Scler."},{"issue":"Suppl 2","key":"10.1016\/j.msard.2026.107930_bib0073","doi-asserted-by":"crossref","first-page":"S883","DOI":"10.1007\/s100720070031","article-title":"Imaging axonal damage in multiple sclerosis by means of MR spectroscopy","volume":"21","author":"De Stefano","year":"2000","journal-title":"Neurol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2026.107930_bib0064","first-page":"31S","article-title":"MR spectroscopy in multiple sclerosis","volume":"17","author":"De Stefano","year":"2007","journal-title":"J. Neuroimaging"},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0019","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jmri.25139","article-title":"Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: proof of concept in multiple sclerosis","volume":"44","author":"Donadieu","year":"2016","journal-title":"J. Magn. Reson. Imaging"},{"issue":"9","key":"10.1016\/j.msard.2026.107930_bib0072","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0284185116683575","article-title":"Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study","volume":"58","author":"Duan","year":"2017","journal-title":"Acta Radiol."},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0026","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuroimage.2011.12.038","article-title":"The neurochemical profile quantified by in vivo 1H NMR spectroscopy","volume":"61","author":"Duarte","year":"2012","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09674845.2013.11669939","article-title":"Glutathione in multiple sclerosis","volume":"70","author":"Ferreira","year":"2013","journal-title":"Br. J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.msard.2026.107930_bib0027","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult. Scler."},{"issue":"Pt 1","key":"10.1016\/j.msard.2026.107930_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/brain\/120.1.15","article-title":"Executive function in multiple sclerosis. The role of frontal lobe pathology","volume":"120","author":"Foong","year":"1997","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/jnp.11.1.45","article-title":"Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology","volume":"11","author":"Foong","year":"1999","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.msard.2026.107930_bib0058","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2008.05216.x","article-title":"Glutamate induces release of glutathione from cultured rat astrocytes\u2013a possible neuroprotective mechanism?","volume":"105","author":"Frade","year":"2008","journal-title":"J. neurochem."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0006","article-title":"White matter lesion location correlates with disability in relapsing multiple sclerosis","volume":"6","author":"Gaetano","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0057","first-page":"89","article-title":"Glutathione redox imbalance in brain disorders","volume":"18","author":"Gu","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0063","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1148\/radiol.210614","article-title":"Extensive brain pathologic alterations detected with 7.0-T MR spectroscopic imaging associated with disability in multiple sclerosis","volume":"303","author":"Heckova","year":"2022","journal-title":"Radiology."},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0036","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neulet.2005.03.038","article-title":"Voxel-based morphometry to discriminate early Alzheimer's disease from controls","volume":"382","author":"Hirata","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"17","key":"10.1016\/j.msard.2026.107930_bib0041","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.3390\/ijms21176117","article-title":"Current methods of magnetic resonance for noninvasive assessment of molecular aspects of pathoetiology in multiple sclerosis","volume":"21","author":"Hnilicova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0043","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tins.2023.11.005","article-title":"Toward identifying key mechanisms of progression in multiple sclerosis","volume":"47","author":"Husseini","year":"2024","journal-title":"Trends. Neurosci."},{"key":"10.1016\/j.msard.2026.107930_bib0004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2019.03.007","article-title":"Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review","volume":"400","author":"Jameen","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107930_bib0033","first-page":"03","article-title":"Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments","volume":"03","author":"John","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.msard.2026.107930_bib0013","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1191\/1352458505ms1201oa","article-title":"Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis","volume":"11","author":"Lazeron","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107930_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105758","article-title":"Depression and anxiety in MS: symptoms or comorbidity?","volume":"88","author":"Lechner-Scott","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0048","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/RLI.0000000000000913","article-title":"Lesion-specific metabolic alterations in relapsing-remitting multiple sclerosis via 7 t magnetic resonance spectroscopic imaging","volume":"58","author":"Lipka","year":"2023","journal-title":"Invest. Radiol."},{"issue":"5","key":"10.1016\/j.msard.2026.107930_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4309","article-title":"Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations","volume":"34","author":"Maudsley","year":"2021","journal-title":"NMR Biomed."},{"issue":"4-5","key":"10.1016\/j.msard.2026.107930_bib0061","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/15459683221076461","article-title":"Whole-brain metabolic abnormalities are associated with mobility in older adults with multiple sclerosis","volume":"36","author":"Mueller","year":"2022","journal-title":"Neurorehabil. Neural Repair."},{"issue":"8","key":"10.1016\/j.msard.2026.107930_bib0023","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jnnp-2013-306662","article-title":"Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions","volume":"85","author":"Muhlert","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.msard.2026.107930_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.548505","article-title":"Glutamate systems in DSM-5 anxiety disorders: their role and a review of glutamate and GABA psychopharmacology","volume":"11","author":"Nasir","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.msard.2026.107930_bib0040","series-title":"Multiple sclerosis: etiology, diagnosis, and new treatment strategies","author":"Olek","year":"2007"},{"issue":"8","key":"10.1016\/j.msard.2026.107930_bib0044","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.WNL.0000090564.88719.37","article-title":"Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis","volume":"61","author":"Pitt","year":"2003","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.msard.2026.107930_bib0009","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1352458511398265","article-title":"Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location","volume":"17","author":"Reuter","year":"2011","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0059","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nic.2008.08.002","article-title":"Proton magnetic resonance spectroscopy in multiple sclerosis","volume":"19","author":"Sajja","year":"2009","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"7","key":"10.1016\/j.msard.2026.107930_bib0065","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00415-002-0758-5","article-title":"Localized 1H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis","volume":"249","author":"Sarchielli","year":"2002","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107930_bib0071","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/nbm.2772","article-title":"Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology","volume":"25","author":"Shungu","year":"2012","journal-title":"NMR Biomed."},{"key":"10.1016\/j.msard.2026.107930_bib0042","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nicl.2018.07.012","article-title":"Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis","volume":"20","author":"Solana","year":"2018","journal-title":"Neuroimage Clin."},{"issue":"12","key":"10.1016\/j.msard.2026.107930_bib0031","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3174\/ajnr.A6809","article-title":"NAA is a marker of disability in secondary-progressive MS: a proton MR spectroscopic imaging study","volume":"41","author":"Solanky","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"Pt 5","key":"10.1016\/j.msard.2026.107930_bib0050","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/brain\/awh467","article-title":"Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T","volume":"128","author":"Srinivasan","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0054","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mri.2009.06.008","article-title":"MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis","volume":"28","author":"Srinivasan","year":"2010","journal-title":"Magn. Reson. Imaging"},{"issue":"4","key":"10.1016\/j.msard.2026.107930_bib0069","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000347090","article-title":"A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder","volume":"67","author":"Strawn","year":"2013","journal-title":"Neuropsychobiology."},{"issue":"14","key":"10.1016\/j.msard.2026.107930_bib0039","article-title":"Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging","volume":"96","author":"Sun","year":"2017","journal-title":"Med. (Baltim.)"},{"issue":"11","key":"10.1016\/j.msard.2026.107930_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4590","article-title":"In vivo evidence of differential frontal cortex metabolic abnormalities in progressive and relapsing-remitting multiple sclerosis","volume":"34","author":"Swanberg","year":"2021","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17741-8","article-title":"Multiple sclerosis diagnosis and phenotype identification by multivariate classification of in vivo frontal cortex metabolite profiles","volume":"12","author":"Swanberg","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.msard.2026.107930_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061817","article-title":"Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans","volume":"8","author":"Tisell","year":"2013","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0062","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2463\/mrms.rev.2021-0085","article-title":"In vivo human MR spectroscopy using a clinical scanner: development, applications, and future prospects","volume":"21","author":"Tomiyasu","year":"2022","journal-title":"Magn. Reson. Med. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/hbm.22229","article-title":"Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI","volume":"35","author":"Tur","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.msard.2026.107930_bib0034","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3892\/etm.2023.12048","article-title":"Early metabolic alterations in the normal\u2011appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: a proton MR spectroscopic study","volume":"26","author":"Tzanetakos","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.msard.2026.107930_bib0010","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuroimage.2013.05.125","article-title":"Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis","volume":"82","author":"Vingara","year":"2013","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.msard.2026.107930_bib0046","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.1077","article-title":"Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage","volume":"50","author":"Werner","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107930_bib0028","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/nbm.3063","article-title":"Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging","volume":"27","author":"Wiebenga","year":"2014","journal-title":"NMR Biomed."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600965X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600965X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:42:07Z","timestamp":1793954527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600965X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":73,"alternative-id":["S221103482600965X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107930","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurometabolic brain changes in MS associated with fatigue and anxiety","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107930"}}